The world's first biotech company for personalized skincare by combining epigenetics and blockchain technology

Symbol EPIC
Total Supply 100,000,000
Platform Ethereum
Category Biotech, Big data, Cosmetics
Start Date 19/03/2018
Finish Date 01/06/2018
White Paper Open


Scientifically Grounded

How does a consumer know whether a skincare product is truly working for them? EpigenCare is connecting consumers with skincare companies through a direct-to-consumer skincare test and web platform on the Ethereum network. Consumers will be able to receive actionable recommendations of optimized skincare products to use, as well as assess the progress of their skincare routines, based on their skin’s epigenetic profiles. The recommendation engine looks at the functional state of a panel of epigenetic markers strongly correlated with skin quality indicators (e.g., aging, moisture retention, elasticity, etc.), and how skincare product ingredients affect them.

Truly Tokenized Ecosystem

As epigenetics regulates gene function and dynamically changes based on environmental stimuli such as skincare product ingredients, it is a perfect fit for a recurring, tokenized business model. EpigenCare’s upcoming platform will be a structured ecosystem that allows skincare companies to target data segments with products that fulfill the recommendation engine’s matching requirements. Consumers that fall within the segment are rewarded with tokens, which can be used to subsidize additional tests (thereby generating additional advertising inventory for companies).

Disrupting the Skincare Industry

Our structured ecosystem allows for true leveraging of blockchain technology. The recurring nature of epigenetics allows for a cyclical incentivization model through data tokenization. By associating a transaction hash ID with each purchased test and data segment, we will be able to transparently prove that a consumer’s data is used only for their own benefit, thereby addressing the problem of perceived intrusiveness often associated with commercialized DNA-related testing. EpigenCare’s disruptive innovation introduces a new marketing channel to the $130 billion
skincare industry and transforms the way companies market their products to consumers through scientifically screened, individualized advertising.

Scroll to top